| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Oladaterol |
| Brand | Striverdi®, Respimat® |
| Indication | As a maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD). |
| Assessment Process | |
| Rapid review commissioned | 07/04/2014 |
| Rapid review completed | 02/05/2014 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |